From the Journals

'Deep learning' AI shows benefit in colonoscopy in U.S. population


 

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Reducing miss rates matters

“Missed adenomas can be associated with the development of interval colorectal cancer, so whether novel technologies such as artificial intelligence-based computer-aided polyp detection system can decrease adenoma miss rate is of interest,” said Atsushi Sakuraba, MD, of the University of Chicago, in an interview.

Dr Sakuraba said he was not surprised by the current study findings, as several pilot and randomized studies have shown the benefits of AI-based polyp detection systems. As for how the AI-assisted technology might improve practice, he said it may be a valuable addition. “Adenoma miss rate was significantly lower with an AI-based polyp detection system, so it might lead to decreased colorectal cancer,” he explained. “Various methods to improve adenoma detection should complement each other.

Dr. Sakuraba also commented that additional research is needed outside of academic centers, noting “further studies in the community setting involving various endoscopists are required to confirm generalizability.”

Lead author Dr. Glissen Brown had no financial conflicts to disclose. This was an investigator-initiated study, with research software and study funding provided by Wision. Dr. Sakuraba disclosed collaborative research with Fuji film, which was not involved in this study.

Pages

Recommended Reading

Antibiotic use and colon cancer: More evidence of link
MDedge Hematology and Oncology
Gastric cancer: Family history–based H. pylori strategy would be cost effective
MDedge Hematology and Oncology
Linked-color imaging outperforms other modalities at adenoma detection
MDedge Hematology and Oncology
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
MDedge Hematology and Oncology
Morphology drives optical evaluation’s accuracy for predicting SMIC
MDedge Hematology and Oncology
WATS-3D plus Seattle protocol increases dysplasia detection in Barrett’s esophagus
MDedge Hematology and Oncology
Use live donors for liver transplants for HCC patients, say experts
MDedge Hematology and Oncology
Priming tremelimumab dose regimen shows promising benefit-risk profile in HCC
MDedge Hematology and Oncology
Few poorly prepped colonoscopies repeated within 1 year
MDedge Hematology and Oncology
Donafenib shows potential as first-line treatment of advanced hepatocellular carcinoma
MDedge Hematology and Oncology